Insider Trading History of Zalevsky Jonathan


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Zalevsky Jonathan since year 2005. The trader's CIK number is 1789857. At the time of the last reporting, Zalevsky Jonathan was the Chief R&D Officer of Nektar Therapeutics . (stock ticker symbol NKTR). See this page for all insider trading activities at Nektar Therapeutics .


Stock purchases, sales, and option exercises reported by insider Zalevsky Jonathan since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2020-02-18 NKTR Nektar Therapeutics Sale 4,774 22.35 106,698
2019-11-18 NKTR Nektar Therapeutics Sale 3,960 17.97 71,161

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Zalevsky Jonathan (Chief R&D Officer of Nektar Therapeutics at the time of this reporting) see the Securities and Exchange Commission (SEC) website.




Real-time Insider Trading

Insider Officer Cluster Trading

Top Officer Buys of the Week

Top Officer Buys of the Month